IN2013MU02470A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU02470A IN2013MU02470A IN2470MU2013A IN2013MU02470A IN 2013MU02470 A IN2013MU02470 A IN 2013MU02470A IN 2470MU2013 A IN2470MU2013 A IN 2470MU2013A IN 2013MU02470 A IN2013MU02470 A IN 2013MU02470A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Priority Applications (22)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2470MU2013 IN2013MU02470A (US08188275-20120529-C00012.png) | 2013-07-25 | 2013-07-25 | |
| NZ714558A NZ714558A (en) | 2013-07-25 | 2014-07-24 | Formulation comprising a hypolipidemic agent |
| SG11201509798PA SG11201509798PA (en) | 2013-07-25 | 2014-07-24 | Formulation comprising a hypolipidemic agent |
| MA38865A MA38865A1 (fr) | 2013-07-25 | 2014-07-24 | Formulation comprenant un agent hypolipidémiant |
| KR1020157036380A KR101786843B1 (ko) | 2013-07-25 | 2014-07-24 | 지질 저하제를 포함하는 제제 |
| EA201690072A EA201690072A1 (ru) | 2013-07-25 | 2014-07-24 | Состав, содержащий гиполипидемическое средство |
| CA2917923A CA2917923A1 (en) | 2013-07-25 | 2014-07-24 | Formulation comprising a hypolipidemic agent |
| BR112015031878A BR112015031878A2 (pt) | 2013-07-25 | 2014-07-24 | composição farmacêutica |
| AU2014294548A AU2014294548B2 (en) | 2013-07-25 | 2014-07-24 | Formulation comprising a hypolipidemic agent |
| CN201480041453.7A CN105407873A (zh) | 2013-07-25 | 2014-07-24 | 包含降血脂剂的制剂 |
| TW103125304A TW201545773A (zh) | 2013-07-25 | 2014-07-24 | 包含降血脂劑的調合物 |
| US14/899,912 US9610277B2 (en) | 2013-07-25 | 2014-07-24 | Formula comprising a hypolipidemic agent |
| EP14787059.6A EP3024446A1 (en) | 2013-07-25 | 2014-07-24 | Formulation comprising a hypolipidemic agent |
| MX2015016971A MX2015016971A (es) | 2013-07-25 | 2014-07-24 | Formulacion que comprende un agente hipolipidemico. |
| JP2016522969A JP2016523895A (ja) | 2013-07-25 | 2014-07-24 | 脂質低下剤を含む製剤 |
| PCT/IN2014/000489 WO2015011730A1 (en) | 2013-07-25 | 2014-07-24 | Formulation comprising a hypolipidemic agent |
| ARP140102777A AR097067A1 (es) | 2013-07-25 | 2014-07-25 | Formulación que comprende un agente hipolipidémico |
| AP2015008876A AP2015008876A0 (en) | 2013-07-25 | 2015-07-24 | Formulation comprising a hypolipidemic agent |
| ZA2015/08682A ZA201508682B (en) | 2013-07-25 | 2015-11-25 | Formulation comprising a hypolipidemic agent |
| PH12015502802A PH12015502802A1 (en) | 2013-07-25 | 2015-12-17 | Formulation comprising a hypolipidemic agent |
| HK16107193.2A HK1219222A1 (zh) | 2013-07-25 | 2016-06-21 | 包含降血脂藥的製劑 |
| US15/475,812 US10098868B2 (en) | 2013-07-25 | 2017-03-31 | Formula comprising a hypolipidemic agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2470MU2013 IN2013MU02470A (US08188275-20120529-C00012.png) | 2013-07-25 | 2013-07-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU02470A true IN2013MU02470A (US08188275-20120529-C00012.png) | 2015-06-26 |
Family
ID=51787141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2470MU2013 IN2013MU02470A (US08188275-20120529-C00012.png) | 2013-07-25 | 2013-07-25 |
Country Status (21)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007136290A1 (en) | 2006-05-23 | 2007-11-29 | Intel Corporation | Millimeter-wave communication system with directional antenna and one or more millimeter-wave reflectors |
| SG191772A1 (en) | 2011-01-31 | 2013-08-30 | Cadila Healthcare Ltd | Treatment for lipodystrophy |
| GEP201706663B (en) | 2013-04-22 | 2017-05-10 | Cadila Healthcare Ltd | Novel composition for nonalcoholic fatty liver disease (nafld |
| EP3004053B1 (en) | 2013-05-30 | 2021-03-24 | Cadila Healthcare Limited | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
| TW201513857A (zh) | 2013-07-05 | 2015-04-16 | Cadila Healthcare Ltd | 協同性組成物 |
| IN2013MU02470A (US08188275-20120529-C00012.png) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
| IN2013MU02905A (US08188275-20120529-C00012.png) | 2013-09-06 | 2015-07-03 | Cadila Healthcare Ltd | |
| WO2017064635A2 (en) | 2015-10-14 | 2017-04-20 | Cadila Healthcare Limited | Pyrrole compound, compositions and process for preparation thereof |
| KR101913830B1 (ko) * | 2016-12-05 | 2018-10-31 | 주식회사 코쿤디자인 | 기능성 led 어셈블리를 이용한 디스플레이 장치 |
| JP6840853B2 (ja) | 2016-12-09 | 2021-03-10 | カディラ・ヘルスケア・リミテッド | 原発性胆汁性胆管炎の治療 |
| WO2020165782A1 (en) * | 2019-02-13 | 2020-08-20 | Cadila Healthcare Limited | Treatment for polycystic ovarian syndrome (pcos) |
| WO2020183379A1 (en) * | 2019-03-11 | 2020-09-17 | Cadila Healthcare Limited | Novel salts, crystalline forms and premix of hypolipidemic agent |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4231938A (en) | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
| US4444784A (en) | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| MX7065E (es) | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
| US5354772A (en) | 1982-11-22 | 1994-10-11 | Sandoz Pharm. Corp. | Indole analogs of mevalonolactone and derivatives thereof |
| US5030447A (en) * | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
| FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
| US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| SK695A3 (en) | 1992-07-03 | 1995-07-11 | Smithkline Beecham Plc | Heterocyclic compounds method of their production and using |
| GB9225386D0 (en) | 1992-12-04 | 1993-01-27 | Smithkline Beecham Plc | Novel compounds |
| US5387613A (en) | 1993-07-23 | 1995-02-07 | Ribogene, Inc. | Treatment of tachyarrhythmias of supraventricular origin |
| GB9326171D0 (en) | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Novel compounds |
| WO1996004261A1 (en) | 1994-07-29 | 1996-02-15 | Smithkline Beecham Plc | Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes |
| CN1094940C (zh) | 1995-04-28 | 2002-11-27 | 第一制药株式会社 | 具有抗肿瘤活性的紫杉酚衍生物 |
| GB9600464D0 (en) | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
| GB9606805D0 (en) | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
| US6130214A (en) | 1997-10-27 | 2000-10-10 | Dr. Reddy's Research Foundation | Benzothiazin and benzoxazin derivatives; their preparation and uses |
| WO1999019313A1 (en) | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
| AU1120599A (en) | 1998-04-23 | 1999-03-08 | Dr. Reddy's Research Foundation | New heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them |
| PL341795A1 (en) | 1998-05-27 | 2001-05-07 | Reddy Research Foundation | Bicycle compounds, process for obtaining them and pharmacological compositions containing such compounds |
| EP1123292A1 (en) | 1998-10-21 | 2001-08-16 | Novo Nordisk A/S | New compounds, their preparation and use |
| WO2000023451A1 (en) | 1998-10-21 | 2000-04-27 | Novo Nordisk A/S | New compounds, their preparation and use |
| WO2000023417A1 (en) | 1998-10-21 | 2000-04-27 | Novo Nordisk A/S | New compounds, their preparation and use |
| CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| AP1522A (en) | 2000-01-19 | 2005-12-22 | Cadila Healthcare Ltd | Compounds having hypolipedemic and hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them. |
| US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| WO2002024625A2 (en) | 2000-09-22 | 2002-03-28 | Dr. Reddy's Research Foundation | Process for the preparation of 3-aryl-2-hydroxy propanoic acid derivatives |
| UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| US6987123B2 (en) | 2001-07-26 | 2006-01-17 | Cadila Healthcare Limited | Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| JP4745616B2 (ja) * | 2003-02-26 | 2011-08-10 | 武田薬品工業株式会社 | 安定化されたイミダゾール誘導体含有医薬組成物、イミダゾール誘導体の安定化方法 |
| WO2005031335A1 (ja) | 2003-09-26 | 2005-04-07 | Mitsubishi Rayon Co., Ltd. | 電気泳動装置および電気泳動法並びにそれを用いた生体関連物質の検出方法 |
| CN102134231B (zh) | 2004-03-15 | 2020-08-04 | 武田药品工业株式会社 | 二肽基肽酶抑制剂 |
| DE602007009489D1 (de) * | 2006-02-22 | 2010-11-11 | Eisai R&D Man Co Ltd | Stabilisierte pharmazeutische zusammensetzung |
| EP2018157A2 (en) | 2006-04-26 | 2009-01-28 | Astron Research Limited | Controlled release formulation comprising anti-epileptic drugs |
| JP5424571B2 (ja) * | 2007-04-12 | 2014-02-26 | 協和発酵キリン株式会社 | トピラマート含有固形製剤 |
| HUE039731T2 (hu) | 2009-11-26 | 2019-01-28 | Genfit | l,3-difenilprop-2-én-l-on-származékok alkalmazása májbetegségek kezelésére |
| CN103347506A (zh) * | 2010-10-12 | 2013-10-09 | 约翰.霍普金斯大学 | 包含美金刚的镇咳组合物 |
| SG191772A1 (en) * | 2011-01-31 | 2013-08-30 | Cadila Healthcare Ltd | Treatment for lipodystrophy |
| GEP201706663B (en) * | 2013-04-22 | 2017-05-10 | Cadila Healthcare Ltd | Novel composition for nonalcoholic fatty liver disease (nafld |
| EP3004053B1 (en) | 2013-05-30 | 2021-03-24 | Cadila Healthcare Limited | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
| TW201513857A (zh) | 2013-07-05 | 2015-04-16 | Cadila Healthcare Ltd | 協同性組成物 |
| IN2013MU02470A (US08188275-20120529-C00012.png) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
| IN2013MU02828A (US08188275-20120529-C00012.png) | 2013-08-29 | 2015-07-03 | Cadila Healthcare Ltd | |
| IN2013MU02905A (US08188275-20120529-C00012.png) | 2013-09-06 | 2015-07-03 | Cadila Healthcare Ltd |
-
2013
- 2013-07-25 IN IN2470MU2013 patent/IN2013MU02470A/en unknown
-
2014
- 2014-07-24 AU AU2014294548A patent/AU2014294548B2/en not_active Expired - Fee Related
- 2014-07-24 US US14/899,912 patent/US9610277B2/en active Active
- 2014-07-24 NZ NZ714558A patent/NZ714558A/en not_active IP Right Cessation
- 2014-07-24 SG SG11201509798PA patent/SG11201509798PA/en unknown
- 2014-07-24 WO PCT/IN2014/000489 patent/WO2015011730A1/en active Application Filing
- 2014-07-24 CA CA2917923A patent/CA2917923A1/en not_active Abandoned
- 2014-07-24 TW TW103125304A patent/TW201545773A/zh unknown
- 2014-07-24 JP JP2016522969A patent/JP2016523895A/ja active Pending
- 2014-07-24 MX MX2015016971A patent/MX2015016971A/es active IP Right Grant
- 2014-07-24 EP EP14787059.6A patent/EP3024446A1/en not_active Withdrawn
- 2014-07-24 BR BR112015031878A patent/BR112015031878A2/pt not_active IP Right Cessation
- 2014-07-24 CN CN201480041453.7A patent/CN105407873A/zh active Pending
- 2014-07-24 KR KR1020157036380A patent/KR101786843B1/ko active IP Right Grant
- 2014-07-24 EA EA201690072A patent/EA201690072A1/ru unknown
- 2014-07-24 MA MA38865A patent/MA38865A1/fr unknown
- 2014-07-25 AR ARP140102777A patent/AR097067A1/es unknown
-
2015
- 2015-07-24 AP AP2015008876A patent/AP2015008876A0/xx unknown
- 2015-11-25 ZA ZA2015/08682A patent/ZA201508682B/en unknown
- 2015-12-17 PH PH12015502802A patent/PH12015502802A1/en unknown
-
2016
- 2016-06-21 HK HK16107193.2A patent/HK1219222A1/zh unknown
-
2017
- 2017-03-31 US US15/475,812 patent/US10098868B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR101786843B1 (ko) | 2017-10-18 |
| EP3024446A1 (en) | 2016-06-01 |
| SG11201509798PA (en) | 2016-02-26 |
| US10098868B2 (en) | 2018-10-16 |
| HK1219222A1 (zh) | 2017-03-31 |
| WO2015011730A1 (en) | 2015-01-29 |
| MA38865A1 (fr) | 2017-12-29 |
| AP2015008876A0 (en) | 2015-11-30 |
| PH12015502802A1 (en) | 2016-03-14 |
| US9610277B2 (en) | 2017-04-04 |
| AU2014294548A1 (en) | 2015-12-17 |
| US20170266158A1 (en) | 2017-09-21 |
| CA2917923A1 (en) | 2015-01-29 |
| NZ714558A (en) | 2017-02-24 |
| KR20160013150A (ko) | 2016-02-03 |
| AU2014294548B2 (en) | 2017-08-10 |
| BR112015031878A2 (pt) | 2017-07-25 |
| US20160136131A1 (en) | 2016-05-19 |
| TW201545773A (zh) | 2015-12-16 |
| CN105407873A (zh) | 2016-03-16 |
| ZA201508682B (en) | 2017-03-29 |
| MX2015016971A (es) | 2016-04-25 |
| EA201690072A1 (ru) | 2016-06-30 |
| JP2016523895A (ja) | 2016-08-12 |
| AR097067A1 (es) | 2016-02-17 |
